Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
8-4
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #11.4
advertisement
11.4 Prostaglandins
(31)
Showing records 1 to 25
Display all abstracts in classification
11.4 Prostaglandins
Search within classification 11.4 Prostaglandins
14982
The effect of unoprostone isopropyl on Ca
2+
release-activated Ca
2+
currents in cultured monkey trabecular meshwork cells and ciliary muscle cells
Shimura M; Yasuda K; Nakzawa T; Kashiwagi K
Journal of Ocular Pharmacology and Therapeutics
2006; 22: 219-226
15138
Prostaglandin F
2
α, but not latanoprost, increases the Ca
2+
sensitivity of the pig iris sphincter muscle
Hasegawa Y; Nishimura J; Niiro N; Hirano K; Ishibashi T; Kanaide H
Investigative Ophthalmology and Visual Science
2006; 47: 4865-4871
14526
Red blood cell (RBC) surface acetylcholinesterase showing a hemorheological pattern during glaucoma treatment
Cicco G; Vetrugno M; Rotelli MT; Sborgia G; Pennetta M; Vico PP; Memeo V; Nitti L; Sborgia C
Clinical Hemorheology and Microcirculation
2006; 35: 149-154
14658
Effect of latanoprost for normal-tension glaucoma by measuring the intraocular pressure at fixed time of day
Mima A; Hata H; Murao F; Shiota H
Japanese Journal of Clinical Ophthalmology
2006; 60: 1613-1616
15284
Changes in glaucoma treatment and achieved IOP after introduction of new glaucoma medication
van der Valk R; Schouten JS; Webers CA; Hendrikse F; Prins MH
Graefe's Archive for Clinical and Experimental Ophthalmology
2006; 244: 1267-1272
15220
Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension
Cantor LB; Hoop J; Morgan L; WuDunn D; Catoira Y; Bimatoprost-Travoprost Study Group
British Journal of Ophthalmology
2006; 90: 1370-1373
15255
Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy
Centofanti M; Oddone F; Chimenti S; Tanga L; Citarella L; Manni G
American Journal of Ophthalmology
2006; 142: 1059-1060
14732
Rescula as an alternative therapy for beta-blockers with long-term drift effect in glaucoma patients
Chen C-L; Tseng H-Y; Wu K-Y
The Kaohsiung Journal of Medical Sciences
2006; 22: 266-270
14719
Effects of bimatoprost 0.03% on ocular hemodynamics in normal tension glaucoma
Chen M-J; Cheng C-Y; Chen Y-C; Chou C-K; Hsu W-M
Journal of Ocular Pharmacology and Therapeutics
2006; 22: 188-193
14950
Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost
Covert D; Robin AL
Current Medical Research and Opinion
2006; 22: 971-976
14415
A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma
Dirks MS; Noecker RJ; Earl M; Roh S; Silverstein SM; Williams RD
Advances in Therapy
2006; 23: 385-394
15168
Clinical course of bimatoprost-induced periocular skin changes in Caucasians
Doshi M; Edward DP; Osmanovic S
Ophthalmology
2006; 113: 1961-1967
14548
Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with open-angle glaucoma or ocular hypertension
Franks W
Current Medical Research and Opinion
2006; 22: 1643-1649
14547
Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%
Garcia Feijoo J; Martinez De La Casa JM; Castillo A; Mendez C; Fernandez Vidal A; Garcia Sanchez J
Current Medical Research and Opinion
2006; 22: 1689-1697
15136
Short-term effects of latanoprost on anterior chamber depth in patients with glaucoma or ocular hypertension
Gutierrez-Ortiz C; Teus MA; Bolivar G
Investigative Ophthalmology and Visual Science
2006; 47: 4856-4859
14565
Travoprost/timolol
Hoy SM; Keam SJ; Keating GM
Drugs and Aging
2006; 23: 587-597
15267
Effects of latanoprost on rodent intraocular pressure
Husain S; Whitlock NA; Rice DS; Crosson CE
Experimental Eye Research
2006; 83: 1453-1458
15018
Adverse reaction after use of latanoprost in Japanese glaucoma patients
Inoue K; Wakakura M; Inoue J; Matsuo H; Hara T; Tomita G
Nippon Ganka Gakkai Zasshi
2006; 110: 581-587
15304
Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials
Li N; Chen XM; Zhou Y; Wei ML; Yao X
Clinical and Experimental Ophthalmology
2006; 34: 755-764
15314
Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mitogen-activated protein kinase
Nakanishi Y; Nakamura M; Mukuno H; Kanamori A; Seigel GM; Negi A
Experimental Eye Research
2006; 83: 1108-1117
14901
Combined therapy in glaucoma treatment: travoprost 0.004% and brinzolamid
Popovic Suic S; Vukojevic N; Cerovski B; Jukic T
Acta Medica Croatica
2006; 60: 101-103
14490
The Slovak study of the travoprost treatment efficacy
Potocky M
Česka a Slovenska Oftalmologie
2006; 62: 263-269
14545
Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension
Suzuki Jr ER; Franklin LM; Basilio Da Silva LJ; Figueiredo CRL; Netto JA; Batista WD
Current Medical Research and Opinion
2006; 22: 1799-1805
14436
A comparison of latanoprost monotherapy with a combination therapy of timolol/dorzolamide in patients with primary open-angle glaucoma
Caca I; Simsek H; Unlu K; Ari S; Keklikci U
Annals of ophthalmology (Skokie, Ill.)
2006; 38: 111-115
15176
Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma
Ishibashi S; Hirose N; Tawara A; Kubota T
Journal of Glaucoma
2006; 15: 354-357
«
1
2
»
Issue
8-4
Table of Contents
Editor's Selection
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement